Related Experiment Videos
Human platelet vasopressin receptors
Life Sciences
|February 1, 1982
Summary
Researchers found specific binding sites for arginine-vasopressin (AVP) on human platelets. This platelet AVP receptor is similar to the kidney receptor and may influence serotonin release and platelet aggregation.
Area of Science:
- Endocrinology
- Pharmacology
- Hematology
Background:
- Arginine-vasopressin (AVP) is a key hormone regulating water balance and blood pressure.
- Platelets play crucial roles in hemostasis and thrombosis.
- Understanding AVP's interaction with platelets could reveal new physiological insights.
Purpose of the Study:
- To characterize specific binding of AVP to human platelets.
- To determine the affinity and density of platelet AVP receptors.
- To compare the platelet AVP receptor with known AVP receptors in other tissues.
Main Methods:
- Incubation of human platelets with radiolabeled 125I-arginine-vasopressin.
- Saturation binding assays to determine receptor affinity (KD) and density (Bmax).
- Pharmacological inhibition studies using AVP analogues.
Main Results:
- Specific, saturable binding of 125I-AVP to human platelets was observed.
- Mean dissociation constant (KD) was 5.6 nM, and mean maximum binding (Bmax) was 115 fmoles/mg protein.
- Platelet AVP receptor characteristics closely resemble those of the kidney medulla receptor.
Conclusions:
- Human platelets possess specific AVP binding sites.
- The platelet AVP receptor shares similarities with the kidney medulla receptor.
- Platelet AVP receptor function may be linked to serotonin release and platelet aggregation, offering a method to assess AVP receptor status in humans.